DE
DGX icon

DV Equities’s Quest Diagnostics DGX Stock Holding History

DV Equities’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$26.9K Buy
+155
New +$28.2K ﹤0.01% 488

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DV Equities's DGX Position: Q4 2025 in Review

DV Equities opened a new position in Quest Diagnostics (DGX) in Q4 2025: 155 shares worth $26.9K. The stake represents ﹤0.01% of the portfolio and ranks #488 among its holdings.

1,050 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

  • DV Equities held 155 shares of Quest Diagnostics worth $26.9K as of Q4 2025.
  • Quest Diagnostics was a new DV Equities position in Q4 2025.
  • Quest Diagnostics made up ﹤0.01% of DV Equities's portfolio in Q4 2025, its #488 holding.
  • 1,050 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on DV Equities's 13F filing for Q4 2025, filed 17 Feb 2026.